Calvert Investment Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
BBHC
Calvert Investment Management's NVS Position: Q1 2017 in Review
Calvert Investment Management sold out of Novartis (NVS) in Q1 2017, closing a stake of 17,431 shares — an estimated $1.14M sold.
Calvert Investment Management first reported a position in NVS in Q2 2013 and held it in 15 quarters. The position peaked at $11.9M in Q4 2015. 909 funds tracked by Wall St. Rank hold NVS as of Q1 2017.
- Calvert Investment Management reported no remaining Novartis position as of Q1 2017 after selling out during the quarter.
- Calvert Investment Management sold 17,431 Novartis shares in Q1 2017, an estimated $1.14M.
- Calvert Investment Management first reported a position in Novartis in Q2 2013 and held it in 15 quarters.
- Calvert Investment Management's Novartis position peaked at $11.9M in Q4 2015.
- 909 funds tracked by Wall St. Rank held Novartis as of Q1 2017.
Based on Calvert Investment Management's 13F filing for Q1 2017.